Former Amgen Exec Sersch Joins Mustang Bio as Chief Medical Officer
Mustang Bio (NASDAQ: MBIO) has appointed Martina Sersch to serve as chief medical officer. Sersch comes to New York-based Mustang from Amgen (NASDAQ: AMGN), where she was executive director. Mustang is developing cell therapies to treat cancer and gene therapies to treat rare, genetic disorders.
Underwriters and Partners
Xpertise: Watch + Learn
Xconomy Insight · Webinar
The New Era of Emerging Therapies Webinar Series
Potential cures and treatments for diseases are on the horizon for a growing number of patients, thanks to recent breakthroughs in CRISPR gene-editing technologies and in cell and gene therapy.
Sponsored · Whitepaper
Protecting Valuable Life Science Assets & Equipment: Monitoring Solutions
Remain compliant and ensure optimal productivity
XiltriX
Xconomy Insight · Special Report
How to Jump 5 Unforeseen Hurdles to Biotech Success – Startup Sourcebook
Insights, wisdom, and inspiration on what it takes
From Our Advertisers
Investment in Wisconsin startups reaches new record total
Tax credits help tech innovators attract capital, fuel growth
Wisconsin Economic Development Corporation